Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$240.69 - $338.77 $136,471 - $192,082
567 Added 19.77%
3,435 $830,000
Q2 2023

Jul 31, 2023

SELL
$271.54 - $344.06 $146,631 - $185,792
-540 Reduced 15.85%
2,868 $986,000
Q1 2023

Aug 02, 2023

BUY
$220.43 - $278.69 $119,032 - $150,492
540 Added 18.83%
3,408 $949,000
Q1 2023

Apr 27, 2023

BUY
$220.43 - $278.69 $751,225 - $949,775
3,408 New
3,408 $949,000
Q1 2021

Apr 23, 2021

SELL
$175.6 - $291.43 $1.15 Million - $1.9 Million
-6,529 Closed
0 $0
Q4 2020

Jan 25, 2021

BUY
$174.98 - $272.83 $232,198 - $362,045
1,327 Added 25.51%
6,529 $1.14 Million
Q3 2020

Dec 14, 2020

BUY
$185.27 - $238.73 $963,774 - $1.24 Million
5,202 New
5,202 $1.01 Million
Q2 2020

Jul 23, 2020

SELL
$153.32 - $191.72 $396,792 - $496,171
-2,588 Closed
0 $0
Q1 2020

Apr 23, 2020

BUY
$124.34 - $193.76 $321,791 - $501,450
2,588 New
2,588 $417,000
Q3 2019

Oct 21, 2019

SELL
$131.82 - $183.4 $0 - $0
0 Closed
0 $0
Q2 2019

Jul 25, 2019

SELL
$124.65 - $167.39 $182,736 - $245,393
-1,466 Closed
0 $0
Q1 2019

Apr 19, 2019

SELL
$115.84 - $160.31 $24,442 - $33,825
-211 Reduced 12.58%
1,466 $215,000
Q4 2018

Jan 23, 2019

BUY
$113.42 - $156.48 $190,205 - $262,416
1,677 New
1,677 $204,000
Q3 2018

Oct 19, 2018

SELL
$121.55 - $156.8 $182,325 - $235,200
-1,500 Closed
0 $0
Q2 2018

Aug 06, 2018

SELL
$112.2 - $165.95 $213,180 - $315,305
-1,900 Reduced 55.88%
1,500 $207,000
Q1 2018

Apr 20, 2018

SELL
$84.6 - $126.1 $617,580 - $920,530
-7,300 Reduced 68.22%
3,400 $393,000
Q4 2017

Jan 23, 2018

SELL
$91.55 - $115.85 $457,750 - $579,250
-5,000 Reduced 31.85%
10,700 $1.01 Million
Q3 2017

Oct 23, 2017

BUY
$79.65 - $90.3 $1.25 Million - $1.42 Million
15,700
15,700 $1.42 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.